Genetic (GENE) Revenue & Revenue Breakdown
Genetic Revenue Highlights
Latest Revenue (Y)
$8.69M
Latest Revenue (Q)
$3.96M
Genetic Revenue by Period
Genetic Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-06-30 | $8.69M | 27.83% |
| 2022-06-30 | $6.79M | 5536.33% |
| 2021-06-30 | $120.55K | 1122.16% |
| 2020-06-30 | $9.86K | -61.23% |
| 2019-06-30 | $25.44K | -86.56% |
| 2018-06-30 | $189.25K | -63.50% |
| 2017-06-30 | $518.51K | -37.12% |
| 2016-06-30 | $824.59K | -59.01% |
| 2015-06-30 | $2.01M | -55.92% |
| 2014-06-30 | $4.56M | 35.15% |
| 2013-06-30 | $3.38M | -70.20% |
| 2012-06-30 | $11.33M | -38.00% |
| 2011-06-30 | $18.28M | 87.31% |
| 2010-06-30 | $9.76M | 46.30% |
| 2009-06-30 | $6.67M | -57.62% |
| 2008-06-30 | $15.74M | 14.37% |
| 2007-06-30 | $13.76M | 39.00% |
| 2006-06-30 | $9.90M | 4.53% |
| 2005-06-30 | $9.47M | 150.29% |
| 2004-06-30 | $3.78M | -59.16% |
| 2003-06-30 | $9.26M | -29.32% |
| 2002-06-30 | $13.11M | 132.68% |
| 2001-06-30 | $5.63M | 40.17% |
| 2000-06-30 | $4.02M | - |
Genetic generated $8.69M in revenue during NA 2023, up 27.83% compared to the previous quarter, and up 4589.66% compared to the same period a year ago.
Genetic Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $3.96M | 62.47% |
| 2023-09-30 | $2.44M | -46.24% |
| 2023-06-30 | $4.53M | 68.79% |
| 2023-03-31 | $2.69M | -35.36% |
| 2022-12-31 | $4.15M | 66.90% |
| 2022-09-30 | $2.49M | -47.53% |
| 2022-06-30 | $4.74M | 64.62% |
| 2022-03-31 | $2.88M | 40.50% |
| 2021-12-31 | $2.05M | 18.73% |
| 2021-09-30 | $1.73M | 1559.16% |
| 2021-06-30 | $104.12K | -84.20% |
| 2021-03-31 | $659.15K | 3910.40% |
| 2020-12-31 | $16.44K | 100.00% |
| 2020-09-30 | $8.22K | -11.42% |
| 2020-06-30 | $9.28K | 100.00% |
| 2020-03-31 | $4.64K | 691.64% |
| 2019-12-31 | $586.00 | 100.00% |
| 2019-09-30 | $293.00 | -95.84% |
| 2019-06-30 | $7.04K | 100.00% |
| 2019-03-31 | $3.52K | -61.73% |
| 2018-12-31 | $9.20K | - |
| 2018-09-30 | $9.20K | -79.88% |
| 2018-06-30 | $45.73K | - |
| 2018-03-31 | $45.73K | -6.47% |
| 2017-12-31 | $48.90K | - |
| 2017-09-30 | $48.90K | -34.53% |
| 2017-06-30 | $74.69K | - |
| 2017-03-31 | $74.69K | -59.54% |
| 2016-12-31 | $184.57K | - |
| 2016-09-30 | $184.57K | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2009-06-30 | - | -100.00% |
| 2008-06-30 | $3.33M | -49.76% |
| 2008-03-31 | $6.63M | 46.04% |
| 2007-12-31 | $4.54M | 2.72% |
| 2007-09-30 | $4.42M | -30.10% |
| 2007-06-30 | $6.32M | 49.14% |
| 2007-03-31 | $4.24M | 109.46% |
| 2006-12-31 | $2.02M | -25.26% |
| 2006-09-30 | $2.71M | 23.61% |
| 2006-06-30 | $2.19M | -14.72% |
| 2006-03-31 | $2.57M | -23.91% |
| 2005-12-31 | $3.38M | 0.01% |
| 2005-09-30 | $3.38M | -426.69% |
| 2005-06-30 | $-1.03M | -129.10% |
| 2005-03-31 | $3.55M | 1.17% |
| 2004-12-31 | $3.51M | - |
Genetic generated $3.96M in revenue during Q2 2024, up 62.47% compared to the previous quarter, and up 159.05% compared to the same period a year ago.
Genetic Revenue Breakdown
Genetic Revenue Breakdown by Country
Annual Revenue by Country
| Country | Jun 22 |
|---|---|
| Asia Pacifics | - |
| Europe MiddleEast and Africa | - |
Genetic Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| A | Agilent | $6.83B | $1.58B |
| MDXH | MDxHealth SA | $70.19M | $19.83M |
| BIOC | Biocept | $25.86M | $589.00K |
| PRPO | Precipio | $12.40M | $3.43M |
| GENE | Genetic | $8.69M | $3.96M |
| TTOO | T2 Biosystems | $7.19M | $1.95M |
| HTGM | HTG Molecular Diagnostics | $6.37M | $1.03M |
| INBS | Intelligent Bio Solutions | $1.26M | $823.80K |
| SERA | Sera Prognostics | $306.00K | - |
| SQL | SeqLL | $1.18K | - |
| BIAF | bioAffinity | - | $2.41B |
GENE Revenue FAQ
What is Genetic’s yearly revenue?
Genetic's yearly revenue for 2023 was $8.69M, representing an increase of 27.83% compared to 2022. The company's yearly revenue for 2022 was $6.79M, representing an increase of 5536.33% compared to 2021. GENE's yearly revenue for 2021 was $120.55K, representing an increase of 1122.16% compared to 2020.
What is Genetic’s quarterly revenue?
Genetic's quarterly revenue for Q2 2024 was $3.96M, a 62.47% increase from the previous quarter (Q1 2024), and a -4.70% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $2.44M, a -46.24% decrease from the previous quarter (Q4 2023), and a -2.11% decrease year-over-year (Q1 2023). GENE's quarterly revenue for Q4 2023 was $4.53M, a 68.79% increase from the previous quarter (Q3 2023), and a -4.46% decrease year-over-year (Q4 2022).
What is Genetic’s revenue growth rate?
Genetic's revenue growth rate for the last 3 years (2021-2023) was 7105.17%, and for the last 5 years (2019-2023) was 34038.18%.